Ledger.Open graph →
SEC Form D · filed June 27, 2018

Beta Cat Pharmaceuticals, Inc

Offering
$6.0M
Sold
$2.6M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
HOUSTON, TX
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Jonathan Northrup · Houston, TXDirectorRahul Aras · Houston, TXExecJoe Cunningham · Houston, TXDirectorUma Bhatt · Houston, TXExecJames Eadie · Houston, TXDirectorKenneth Carter · Germantown, MDDirectorJonathan Northrup · Houston, TXDirectorJames Eadie · Menlo Park, CADirectorRahul Aras · Cleveland, OHExecKenneth Carter · Gaithersburg, MDDirectorJoe Cunningham · Austin, TXDirectorUma Bhatt · Houston, TXExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗